Rising Number Of Pet Owners Fuels Growth In Companion Animal Diagnostics: A Game-Changing Factor in the Companion Animal Diagnostics Market’s Future Growth

 

The companion animal diagnostics market size has grown strongly in recent years. It will grow from $3.1 billion in 2024 to $3.4 billion in 2025 at a compound annual growth rate (CAGR) of 9.9%.  The growth in the historic period can be attributed to increasing pet ownership, rising veterinary healthcare expenditure, growing awareness of pet health, expanding pet insurance adoption, increased prevalence of zoonotic diseases, and growing demand for early disease detection in pets.

The companion animal diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.91 billion in 2029 at a compound annual growth rate (CAGR) of 9.6%.  The growth in the forecast period can be attributed to the growing adoption of point-of-care testing, increasing availability of advanced diagnostic tools, rising demand for personalized veterinary care, expanding telemedicine services for pets, increasing focus on preventive healthcare, and growing investment in diagnostic product development by market players. Major trends in the forecast period include the expansion of telehealth diagnostics for pets, integration of wearable diagnostic devices, growth in molecular diagnostic techniques, the development of personalized veterinary diagnostics, and the adoption of cloud-based diagnostic data management.

Get Your Free Sample of The Global Companion Animal Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20541&type=smp

Which Market drivers have played a significant role in driving the companion animal diagnostics market?
The rising number of pet owners is expected to propel the growth of the companion animal diagnostics market going forward. Pet owners are individuals who possess and take responsibility for the care, well-being, and management of pets. More people are owning pets due to increased recognition of their emotional and health benefits and the rise in accessible pet-related services and products. Companion animal diagnostics help pet owners by providing essential health information and early detection of diseases in their pets, ensuring timely and effective care. For instance, in October 2023, according to the American Pet Products Association, a US-based non-profit association, there were 86.9 million US households that owned a pet, which is 66% of households in 2022. Additionally, in November 2022, according to Animal Medicines Australia, an Australia-based association representing animal health, 69% of households owned pets in Australia in 2022. Therefore, the rising number of pet owners is driving the growth of the companion animal diagnostics market.

What are the key segments within the companion animal diagnostics market?
The companion animal diagnostics market covered in this report is segmented –
1) By Animal Type: Cat, Horse, Dog, Other Animal Types
2) By Technology: Immunodiagnostics, Clinical Biochemistry, Hematology, Urinalysis, Molecular Diagnostics, Other Technologies
3) By Application: Bacteriology, Clinical Pathology, Virology, Parasitology, Other Applications
4) By End-Users: Diagnostics Laboratories, Veterinary Clinics And Hospitals, Research Institutes, Home Care Settings

Subsegments:
1) By Cat: Feline Infectious Disease Testing, Feline Blood Tests, Feline Urinalysis
2) By Horse: Equine Infectious Disease Testing, Equine Blood Tests, Equine Diagnostic Imaging
3) By Dog: Canine Infectious Disease Testing, Canine Blood Tests, Canine Urinalysis
4) By Other Animal Types: Small Mammals, Birds, Reptiles, Exotic Pets

Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/companion-animal-diagnostics-global-market-report

Which key players are shaping the companion animal diagnostics market?
Major companies operating in the companion animal diagnostics market are Thermo Fisher Scientific Inc., Merck KGaA, Fujifilm Holdings Corporation, Zoetis Inc., VCA Inc., Mindray Medical International Limited, bioMérieux S.A., IDEXX Laboratories Inc., Qiagen N.V., Virbac S.A., Randox Laboratories Ltd., Esaote S.p.A., Abaxis Inc., Neogen Corporation, Arkray Inc., Indical Bioscience GmbH, Biovet S.A., Woodley Equipment Company Ltd., Scil Animal Care Company, Laboklin GmbH & Co. KG, VolitionRx Limited

Which transformative trends will shape the companion animal diagnostics market landscape?
Major companies operating in the companion animal diagnostics market are focusing on developing reference laboratories to enhance remote diagnostic capabilities and improve access to specialized care. Reference laboratories are specialized diagnostic labs that provide advanced testing services, often beyond the capabilities of standard clinical laboratories. For instance, in November 2023, Antech Diagnostics, Inc., a US-based veterinary diagnostics company, launched its first comprehensive veterinary diagnostics offering in the UK, which will include a new state-of-the-art reference laboratory located in Warwick. The new diagnostics portfolio aims to provide UK veterinary professionals with a complete and flexible range of services, including reference laboratory services, in-house diagnostics, imaging, and software solutions.

How do regional factors impact the companion animal diagnostics market, and which region is the largest contributor?
North America was the largest region in the companion animal diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the companion animal diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Does The Companion Animal Diagnostics Market Report 2025 Offer?
The companion animal diagnostics market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Companion animal diagnostics refers to the testing and diagnostic procedures used to identify and manage health conditions in pets, such as dogs and cats. This includes a range of tools and services, from blood tests and imaging to specialized assays. It offers early detection and precise management of health conditions, leading to improved outcomes and tailored treatment plans.

Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20541

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.

Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Comments

Popular posts from this blog

2025 Strategic Guide to the Drugs For Benign Prostatic hypertrophy Market – Forecasts and Business Use Cases

Global Antiepileptic Drugs Market Forecast Highlights Growth Outlook And Key Trends Over 2026–2030

Generative Artificial Intelligence (AI) In Telecom Market Industry Outlook Presents Revenue And CAGR Projections To 2030